MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jaip.2022.11.037

Медицинская библиотека · The journal of allergy and clinical immunology. In practice · 2022

Dyslipidemia Is Associated With Worse Asthma Clinical Outcomes: A Prospective Cohort Study.

Liu Lei, Liu Ying, Zhang Xin, Yuan Yu Lai, Chen Zhi Hong, Chen-Yu Hsu Alan, Oliver Brian G, Xie Min, Qin Ling, Li Wei Min, Liu Dan, Wang Gang, Wood Lisa G

Наблюдательное исследованиеСтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Dyslipidemia has been widely documented to be associated with cardiovascular disease, and recent studies have found an association with asthma prevalence. However, longitudinal studies investigating the relationships between dyslipidemia, asthma phenotypes, and future asthma exacerbations (AEs) are lacking.

OBJECTIVE

To investigate the relationships between dyslipidemia, asthma phenotypes, and AEs.

METHODS

This study used an observational cohort study design with a 12-month follow-up. All subjects underwent serum lipid measurement, and they were then classified into 2 groups: the normal-lipidemia group and the dyslipidemia group. Demographic and clinical information and details regarding pulmonary function and asthma phenotypes at baseline were collected. All patients were followed up regularly to assess AEs. Associations of dyslipidemia with airway obstruction and asthma phenotypes were assessed at baseline, whereas dyslipidemia and AEs were assessed longitudinally.

RESULTS

A total of 477 patients with asthma were consecutively enrolled in this study. At baseline, the dyslipidemia group (n = 218) had a higher proportion of uncontrolled asthma, defined by the 6-item Asthma Control Questionnaire score (≥1.5). Furthermore, dyslipidemia was associated with severe asthma, nonallergic asthma, asthma with fixed airflow limitation, and older adult asthma phenotypes at baseline. In addition, dyslipidemia was associated with increased frequencies of severe AEs and moderate to severe AEs during the 12-month follow-up. In sensitivity analyses, after excluding the patients who were receiving statins, results did not differ significantly from those of the main analysis.

CONCLUSIONS

We identified the clinical relevance of dyslipidemia, which is associated with specific asthma phenotypes and increased AEs, independent of other components of metabolic syndrome. These findings highlight the importance of considering dyslipidemia as an "extrapulmonary trait" in asthma management.

Для цитирования: Liu Lei, Liu Ying, Zhang Xin, Yuan Yu Lai, Chen Zhi Hong, Chen-Yu Hsu Alan, Oliver Brian G, Xie Min, Qin Ling, Li Wei Min, Liu Dan, Wang Gang, Wood Lisa G. Dyslipidemia Is Associated With Worse Asthma Clinical Outcomes: A Prospective Cohort Study.. The journal of allergy and clinical immunology. In practice. 2022. DOI: 10.1016/j.jaip.2022.11.037.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.